Chloride-inducible expression vector for delivery of antimicrobial peptides targeting antibiotic-resistant Enterococcus faecium

Applied and Environmental Microbiology

Volumn 81, Issue 11, 2015, Pages 3889-3897

  Geldart, Kathryn ^a   Borrero, Juan ^a   Kaznessis, Yiannis N ^a  

^a University of Minnesota   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACILLI; BACTERIA; GENE EXPRESSION; MICROORGANISMS; PEPTIDES; PROTEINS;

ANTIBIOTIC-RESISTANT BACTERIA; ANTIMICROBIAL PEPTIDE; CHLORIDE CONCENTRATIONS; ENTEROCOCCUS FAECIUM; INDUCIBLE EXPRESSION; PROTEIN EXPRESSION SYSTEMS; PROTEIN EXPRESSIONS; VANCOMYCIN-RESISTANT ENTEROCOCCI;

CHLORINE COMPOUNDS;

ANTIBIOTIC RESISTANCE; BIOCONTROL AGENT; CHLORIDE; CONCENTRATION (COMPOSITION); GENE EXPRESSION; INFECTIOUS DISEASE; MICROBIAL ACTIVITY; PATHOGEN; PEPTIDE;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; LACTOCOCCUS LACTIS;

ANTIMICROBIAL CATIONIC PEPTIDE; CHLORIDE;

ANTIBIOSIS; BACTERIAL LOAD; DRUG EFFECTS; ENTEROCOCCUS FAECIUM; GENE EXPRESSION REGULATION; GENE VECTOR; GENETICS; HUMAN; LACTOCOCCUS LACTIS; METABOLISM; MICROBIAL SENSITIVITY TEST; PROMOTER REGION; TRANSCRIPTION INITIATION;

ANTIBIOSIS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL LOAD; CHLORIDES; ENTEROCOCCUS FAECIUM; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC VECTORS; HUMANS; LACTOCOCCUS LACTIS; MICROBIAL SENSITIVITY TESTS; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84930036140     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00227-15     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
2. Arias CA, Murray BE. 2012. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10:266-278. http://dx.doi.org/10.1038/nrmicro2761.
3. Neely AN, Maley MP. 2000. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38:724-726.
4. Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE. 2012. Unmet needs and prospects for oritavancin in the management of vancomycinresistant enterococcal infections. Clin Infect Dis 54(Suppl 3):S233-S238. http://dx.doi.org/10.1093/cid/cir924.
5. Marothi YA, Agnihotri H, Dubey D. 2005. Enterococcal resistance-an overview. Indian J Med Microbiol 23:214-219.
6. Borrero J, Chen Y, Dunny GM, Kaznessis YN. 2015. Modified lactic acid bacteria detect and inhibit multiresistant enterococci. ACS Synth Biol 4:299-306. http://dx.doi.org/10.1021/sb500090b.
7. Kjos M, Borrero J, Opsata M, Birri DJ, Holo H, Cintas LM, Snipen L, Hernández PE, Nes IF, Diep DB. 2011. Target recognition, resistance, immunity and genome mining of class II bacteriocins from Gram-positive bacteria. Microbiology 157:3256-3267. http://dx.doi.org/10.1099/mic.0.052571-0.
8. Park S-C, Park Y, Hahm K-S. 2011. The role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation. Int J Mol Sci 12:5971-5992. http://dx.doi.org/10.3390/ijms12095971.
9. Klijn N, Weerkamp AH, de Vos WM. 1995. Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl Environ Microbiol 61:2771-2774.
10. Drouault S, Juste C, Marteau P, Renault P, Corthier G. 2002. Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl Environ Microbiol 68:3166-3168. http://dx.doi.org/10.1128/AEM .68.6.3166-3168.2002.
11. Braat H, Rottiers P, Hommes DW, Huyghebaert N, Remaut E, Remon J-P, van Deventer SJH, Neirynck S, Peppelenbosch MP, Steidler L. 2006. A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. Clin Gastroenterol Hepatol 4:754-759. http://dx.doi.org /10.1016/j.cgh.2006.03.028.
12. Sanders JW, Venema G, Kok J. 1997. A chloride-inducible gene expression cassette and its use in induced lysis of Lactococcus lactis. Appl Environ Microbiol 63:4877-4882.
13. Fordtran JS, Locklear TW. 1966. Ionic constituents and osmolality of gastric and small-intestinal fluids after eating. Am J Dig Dis 11:503-521. http://dx.doi.org/10.1007/BF02233563.
14. Kuipers OP, de Ruyter PGG, Kleerebezem M, de Vos WM. 1998. Quorum sensing-controlled gene expression in lactic acid bacteria. J Biotechnol 64:15-21. http://dx.doi.org/10.1016/S0168-1656(98)00100-X.
15. Sanders JW, Leenhouts K, Burghoorn J, Brands JR, Venema G, Kok J. 1998. A chloride-inducible acid resistance mechanism in Lactococcus lactis and its regulation. Mol Microbiol 27:299-310. http://dx.doi.org/10.1046/j.1365-2958.1998.00676.x.
16. Holo H, Nes IF. 1995. Transformation of Lactococcus by electroporation. Methods Mol Biol 47:195-199.
17. Volzing K, Borrero J, Sadowsky MJ, Kaznessis YN. 2013. Antimicrobial peptides targeting Gram-negative pathogens, produced and delivered by lactic acid bacteria. ACS Synth Biol 2:643-650. http://dx.doi.org/10.1021/sb4000367.
18. Kozlowicz BK, Bae T, Dunny GM. 2004. Enterococcus faecalis pheromone-responsive protein PrgX: genetic separation of positive autoregulatory functions from those involved in negative regulation of conjugative plasmid transfer. Mol Microbiol 54:520-532. http://dx.doi.org/10.1111/j .1365-2958.2004.04286.x.
19. Gilbert D, Moellering R, Eliopoulos G Chambers HF, Saag MS (ed). 2013. The Sanford guide to antimicrobial therapy 2013, 43rd ed. Antimicrobial Therapy, Inc, Sperryville, VA.
20. Kjos M, Nes IF, Diep DB. 2011. Mechanisms of resistance to bacteriocins targeting the mannose phosphotransferase system. Appl Environ Microbiol 77:3335-3342. http://dx.doi.org/10.1128/AEM.02602-10.
21. Lewis K. 2013. Platforms for antibiotic discovery. Nat Rev Drug Discov 12:371-387. http://dx.doi.org/10.1038/nrd3975.
22. Rand KH, Houck H. 2004. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci. J Antimicrob Chemother 53:530-532. http://dx.doi.org/10.1093/jac/dkh104.
23. Vaara M, Porro M. 1996. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob Agents Chemother 40:1801-1805.
24. Opsata M, Nes IF, Holo H. 2010. Class IIa bacteriocin resistance in Enterococcus faecalis V583: the mannose PTS operon mediates global transcriptional responses. BMC Microbiol 10:224. http://dx.doi.org/10.1186/1471-2180-10-224.
25. Vadyvaloo V, Hastings JW, van der Merwe MJ, Rautenbach M. 2002. Membranes of class IIa bacteriocin-resistant Listeria monocytogenes cells contain increased levels of desaturated and short-acyl-chain phosphatidylglycerols. Appl Environ Microbiol 68:5223-5230. http://dx.doi.org/10.1128/AEM.68.11.5223-5230.2002.
26. Abadi FJ, Carter PE, Cash P, Pennington TH. 1996. Rifampin resistance in Neisseria meningitidis due to alterations in membrane permeability. Antimicrob Agents Chemother 40:646-651.